Search
Products
Community
Markets
Brokers
More
EN
Get started
Markets
/
USA
/
ETF market
/
LFSC
/
Holdings
F/m Emerald Life Sciences Innovation ETF
LFSC
Nasdaq Stock Market
LFSC
Nasdaq Stock Market
LFSC
Nasdaq Stock Market
LFSC
Nasdaq Stock Market
Market closed
No trades
Overview
Analysis
Holdings
News
Community
Technicals
Seasonals
More
Fund composition
As of May 13, 2026
Symbol
Weight %
Shares
Market value
C
COGT
Cogent Biosciences, Inc.
7.51%
226.14 K
7.75 M
USD
T
TVTX
Travere Therapeutics, Inc.
7.37%
170.71 K
7.61 M
USD
L
LIVN
LivaNova Plc
7.10%
101.21 K
7.33 M
USD
S
SYRE
Spyre Therapeutics, Inc
6.77%
91.59 K
6.99 M
USD
M
MIRM
Mirum Pharmaceuticals, Inc.
5.38%
50.91 K
5.56 M
USD
U
UTHR
United Therapeutics Corporation
4.40%
7.84 K
4.54 M
USD
G
GH
Guardant Health, Inc.
4.26%
44.69 K
4.40 M
USD
N
NKTR
Nektar Therapeutics
3.74%
50.88 K
3.86 M
USD
M
MANE
Veradermics, Incorporated
3.69%
35.57 K
3.81 M
USD
T
TRVI
Trevi Therapeutics, Inc.
3.43%
231.60 K
3.54 M
USD
Get deeper insights with ETF data
Explore detailed ETF holdings data, including weight, shares, and market value.
Unlock more data